Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Chronic pruritus patients with psychiatric and psychosomatic comorbidity are highly burdened: a longitudinal study.

Schneider G, Grebe A, Bruland P, Heuft G, Ständer S.

J Eur Acad Dermatol Venereol. 2019 Mar 9. doi: 10.1111/jdv.15559. [Epub ahead of print] No abstract available.

PMID:
30851203
2.

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis.

Grebe A, Hoss F, Latz E.

Circ Res. 2018 Jun 8;122(12):1722-1740. doi: 10.1161/CIRCRESAHA.118.311362. Review.

PMID:
29880500
3.

Mechanisms of Enhanced Phrenic Long-Term Facilitation in SOD1G93A Rats.

Nichols NL, Satriotomo I, Allen LL, Grebe AM, Mitchell GS.

J Neurosci. 2017 Jun 14;37(24):5834-5845. doi: 10.1523/JNEUROSCI.3680-16.2017. Epub 2017 May 12.

4.

Sit-to-Stand Transition Reveals Acute Fall Risk in Activities of Daily Living.

Pozaic T, Lindemann U, Grebe AK, Stork W.

IEEE J Transl Eng Health Med. 2016 Dec 1;4:2700211. doi: 10.1109/JTEHM.2016.2620177. eCollection 2016.

5.

Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice.

Bode N, Grebe A, Kerksiek A, Lütjohann D, Werner N, Nickenig G, Latz E, Zimmer S.

Biochem Biophys Res Commun. 2016 Sep 9;478(1):356-362. doi: 10.1016/j.bbrc.2016.07.047. Epub 2016 Jul 11.

PMID:
27416761
6.

Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.

Zimmer S, Grebe A, Bakke SS, Bode N, Halvorsen B, Ulas T, Skjelland M, De Nardo D, Labzin LI, Kerksiek A, Hempel C, Heneka MT, Hawxhurst V, Fitzgerald ML, Trebicka J, Björkhem I, Gustafsson JÅ, Westerterp M, Tall AR, Wright SD, Espevik T, Schultze JL, Nickenig G, Lütjohann D, Latz E.

Sci Transl Med. 2016 Apr 6;8(333):333ra50. doi: 10.1126/scitranslmed.aad6100.

7.

Weekly Treatment of 2-Hydroxypropyl-β-cyclodextrin Improves Intracellular Cholesterol Levels in LDL Receptor Knockout Mice.

Walenbergh SM, Houben T, Hendrikx T, Jeurissen ML, van Gorp PJ, Vaes N, Olde Damink SW, Verheyen F, Koek GH, Lütjohann D, Grebe A, Latz E, Shiri-Sverdlov R.

Int J Mol Sci. 2015 Sep 2;16(9):21056-69. doi: 10.3390/ijms160921056.

8.

Danger signaling in atherosclerosis.

Zimmer S, Grebe A, Latz E.

Circ Res. 2015 Jan 16;116(2):323-40. doi: 10.1161/CIRCRESAHA.116.301135. Review.

PMID:
25593277
9.

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.

De Nardo D, Labzin LI, Kono H, Seki R, Schmidt SV, Beyer M, Xu D, Zimmer S, Lahrmann C, Schildberg FA, Vogelhuber J, Kraut M, Ulas T, Kerksiek A, Krebs W, Bode N, Grebe A, Fitzgerald ML, Hernandez NJ, Williams BR, Knolle P, Kneilling M, Röcken M, Lütjohann D, Wright SD, Schultze JL, Latz E.

Nat Immunol. 2014 Feb;15(2):152-60. doi: 10.1038/ni.2784. Epub 2013 Dec 8.

10.

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation.

Sheedy FJ, Grebe A, Rayner KJ, Kalantari P, Ramkhelawon B, Carpenter SB, Becker CE, Ediriweera HN, Mullick AE, Golenbock DT, Stuart LM, Latz E, Fitzgerald KA, Moore KJ.

Nat Immunol. 2013 Aug;14(8):812-20. doi: 10.1038/ni.2639. Epub 2013 Jun 30.

11.

Cholesterol crystals and inflammation.

Grebe A, Latz E.

Curr Rheumatol Rep. 2013 Mar;15(3):313. doi: 10.1007/s11926-012-0313-z. Review.

12.

Derivation and characterization of sleeping beauty transposon-mediated porcine induced pluripotent stem cells.

Kues WA, Herrmann D, Barg-Kues B, Haridoss S, Nowak-Imialek M, Buchholz T, Streeck M, Grebe A, Grabundzija I, Merkert S, Martin U, Hall VJ, Rasmussen MA, Ivics Z, Hyttel P, Niemann H.

Stem Cells Dev. 2013 Jan 1;22(1):124-35. doi: 10.1089/scd.2012.0382. Epub 2012 Nov 2.

PMID:
22989381
13.

IL-1, quo vadis?

Grebe A, Latz E.

Atherosclerosis. 2012 Jun;222(2):324-5. doi: 10.1016/j.atherosclerosis.2012.03.010. Epub 2012 Mar 29. No abstract available.

14.

Recovery of preservation-injured primary human hepatocytes and nonparenchymal cells to tissuelike structures in large-scale bioreactors for liver support: an initial transmission electron microscopy study.

Gerlach JC, Zeilinger K, Grebe A, Puhl G, Pless G, Sauer I, Grünwald A, Schnoy N, Müller C, Neuhaus P.

J Invest Surg. 2003 Mar-Apr;16(2):83-92.

PMID:
12746191
15.

Three-dimensional co-culture of primary human liver cells in bioreactors for in vitro drug studies: effects of the initial cell quality on the long-term maintenance of hepatocyte-specific functions.

Zeilinger K, Sauer IM, Pless G, Strobel C, Rudzitis J, Wang A, Nüssler AK, Grebe A, Mao L, Auth SH, Unger J, Neuhaus P, Gerlach JC.

Altern Lab Anim. 2002 Sep-Oct;30(5):525-38.

PMID:
12405881
16.

Application of time delay spectrometry for rough surface characterization.

Pedersen PC, Grebe A.

Ultrasonics. 2001 Mar;39(2):101-8.

PMID:
11270627
17.

[Liver cell culture in bioreactors for in vitro drug studies as an alternative to animal testing].

Zeilinger K, Auth S, Unger J, Grebe A, Mao L, Petrik M, Holland G, Appel K, Nüssler A, Neuhaus P, Gerlach J.

ALTEX. 2000;17(1):3-10. German.

PMID:
11103107
18.

A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor gene.

Soravia E, Grebe A, De Luca P, Helin K, Suh TT, Degen JL, Blasi F.

Blood. 1995 Jul 15;86(2):624-35.

19.

Monostotic coccidioidal infection; report of a case successfully treated with 2-hydroxystilbamidine.

GREBE AA.

J Bone Joint Surg Am. 1954 Jul;36-A(4):859-62. No abstract available.

PMID:
13174618
20.

Fractures of the shaft of the femur.

GREBE AA.

Am J Surg. 1950 Aug;80(2):161-9. No abstract available.

PMID:
15425701
21.

Complications of treatment of fractures of the shaft of the femur.

STUCK WG, GREBE AA.

South Surg. 1948 Nov;14(11):735-54. No abstract available.

PMID:
18893371

Supplemental Content

Support Center